Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2012, Article ID 405652, 4 pages
http://dx.doi.org/10.1155/2012/405652
Review Article

Surgical Treatment of Peritoneal Carcinomatosis from Gastric Cancer

Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA

Received 6 February 2012; Accepted 11 May 2012

Academic Editor: Lapo Bencini

Copyright © 2012 Kiran K. Turaga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. Kelley and J. M. Duggan, “Gastric cancer epidemiology and risk factors,” Journal of Clinical Epidemiology, vol. 56, no. 1, pp. 1–9, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2006,” Ca-A Cancer Journal for Clinicians, vol. 56, no. 2, pp. 106–130, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Yonemura, Y. Endou, T. Sasaki et al., “Surgical treatment for peritoneal carcinomatosis from gastric cancer.,” European Journal of Surgical Oncology, vol. 36, no. 12, pp. 1131–1138, 2010. View at Google Scholar · View at Scopus
  4. P. Ross, M. Nicolson, D. Cunningham et al., “Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer,” Journal of Clinical Oncology, vol. 20, no. 8, pp. 1996–2004, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Cunningham, W. H. Allum, S. P. Stenning et al., “Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer,” New England Journal of Medicine, vol. 355, no. 1, pp. 11–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. J. Hall, B. W. Loggie, P. Shen et al., “Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer,” Journal of Gastrointestinal Surgery, vol. 8, no. 4, pp. 454–463, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. T. D. Yan, D. Black, P. H. Sugarbaker et al., “A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer,” Annals of Surgical Oncology, vol. 14, no. 10, pp. 2702–2713, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. H. Sugarbaker, “New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?” Lancet Oncology, vol. 7, no. 1, pp. 69–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. V. J. Verwaal, S. Van Ruth, E. De Bree et al., “Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer,” Journal of Clinical Oncology, vol. 21, no. 20, pp. 3737–3743, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. W. P. Ceelen and M. F. Flessner, “Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence,” Nature Reviews Clinical Oncology, vol. 7, no. 2, pp. 108–115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Fujimoto, R. D. Shrestha, M. Kokubun et al., “Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding,” Annals of Surgery, vol. 208, no. 1, pp. 36–41, 1988. View at Google Scholar · View at Scopus
  12. O. Glehen, F. N. Gilly, C. Arvieux et al., “Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy,” Annals of Surgical Oncology, vol. 17, no. 9, pp. 2370–2377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. X. J. Yang, C. Q. Huang, T. Suo et al., “Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial,” Annals of Surgical Oncology, vol. 18, no. 6, pp. 1575–1581, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Kuramoto, S. Shimada, S. Ikeshima et al., “Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma,” Annals of Surgery, vol. 250, no. 2, pp. 242–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Nissan, A. Garofalo, and J. Esquivel, “Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) for gastric adenocarcinoma: why haven't we reached the promised land?” Journal of Surgical Oncology, vol. 102, no. 5, pp. 359–360, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. M. Heiss, P. Murawa, P. Koralewski et al., “The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II/III trial,” International Journal of Cancer, vol. 127, no. 9, pp. 2209–2221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Ströhlein, F. Lordick, D. Rüttinger et al., “Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trial,” Onkologie, vol. 34, no. 3, pp. 101–108, 2011. View at Publisher · View at Google Scholar · View at Scopus